A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions
Candidiasis
Interventions
DRUG

voriconazole

"Subjects 12 - \<18 yrs (excluding subjects 12 - 14 yrs weighing \<50kg): For IC, the loading dose is 6 mg/kg IV q12h on Day 1, followed by 4 mg/kg IV q12h thereafter. Oral therapy, if given, will be administered at a dose of 200 mg q12h. For EC, no loading dose is required, and subjects will be initiated on 3 mg/kg IV q12h. Oral therapy, if given, will be administered at a dose of 200 mg q12h.~Subjects 2 - \<12 yrs, and subjects 12 - 14 weighing \<50kg: For IC, the loading dose is 9 mg/kg IV q12h on Day 1, followed by 8 mg/kg IV q12h thereafter. For EC, no loading dose is required, and subjects will be initiated on 4 mg/kg IV q12. Oral therapy, if given, will be administered at a dose of 9 mg/kg q12h (maximum initial dose of 300 mg).~Subjects will be treated for a minimum of 14 days for invasive candidiasis/candidemia or a minimum of 7 days for esophageal candidiasis. Subjects will be treated for up to a maximum of 42 days."

Trial Locations (14)

0

Department of Paediatrics and Adolescent Medicine, Hong Kong

1000

Medical Research Laboratory Philippine General Hospital University of the Philippines, Ermita

Rm. 112 ICHHD, National Institutes of Health-University of the Philippines Manila, Manila

1085

Semmelweis Egyetem, II. sz. Szemeszeti Klinika, Budapest

1094

Semmelweis Egyetem, II. sz. Gyermekgyogyaszati Klinika, Budapest

1097

Fovarosi Onkormanyzat Egyesitett Szent Istvan és Szent Laszlo Korhaz-Rendelointezet, Budapest

100045

Beijing Children's Hospital, Capital University of Medical Sciences, Beijing

430030

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan

625 00

Fakultni nemocnice Brno - Klinika detske onkologie, Brno

Unknown

Queen Mary Hospital, Hong Kong

The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T.

04530

Instituto Nacional de Pediatria, Colonia Insurgentes Cuicuilco, Delegacion Coyoacan

10-561

Oddzial Pediatryczny I- Hematologiczno-Onkologiczny, Olsztyn

833 40

Detska fakultna nemocnica s poliklinikou Bratislava, Bratislava

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01092832 - A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients | Biotech Hunter | Biotech Hunter